Piperazine-substituted benzothiophenes for treatment of mental disorders
US9839637B1 · kind B1 · utility
1Cited by
10References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2017 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | Sep 6, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2059
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a heterocyclic compound represented by the general formula (1): The compound of the present invention has a wide treatment spectrum for mental disorders including central nervous system disorders, no side effects and high safety.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.